As the world celebrates Hepatitis Day on July 28, 2020, the count of people globally affected by hepatitis would be more than 325 million. Also, the count of annual average deaths by the most prevalent forms of Hepatitis- B & C (HBV and HCV) would be 1.4 million. Being one of the leading causes of death, these two viruses kill more than human immunodeficiency virus (HIV) and malaria and are responsible for two out of every three liver cancer deaths globally.
Hepatitis E virus (HEV) infection is the major cause of acute sporadic and epidemic hepatitis in India. The frequency of hepatitis C has been reported to be 1-2 per cent among voluntary blood donors and about 15-30 per cent cases of acute hepatitis in India is due to HBV.
These numbers may sound terrifying but significant progress is being made in both the prevention and treatment of the various forms of hepatitis. Vaccination is now available for both hepatitis A (HAV) and hepatitis B, and since hepatitis D (HDV) only occurs when a hepatitis B infection is present, this leaves only hepatitis C and hepatitis E in need of a vaccination for prevention.
Also, there are a number of drugs approved by U.S. Food and Drug Administration (FDA) for management of HBV and HCV infections which include interferon therapy- PEG-IFN alfa-2a, PEG- IFN alfa-2b; nucleoside and nucleotide analogues- Adefovir, Entecavir, Emtricitabine, Lamivudine, Ribavirin Telbivudine, Tenofovir; and newer direct-acting antiviral drugs (DAAs)Simeprevir, Sofosbuvir, Ledipasvir, Ombitasvir, Paritaprevir, Dasabuvir, Elbasvir and Grazoprevir, Velpatasvir
This story is from the July 2020 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the July 2020 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Economic Survey Lays Focus On Mental Healthcare For The First Time
For the first time ever, the Economic Survey 2023-24 tabled by the Union Minister of Finance and Corporate Affairs Nirmala Sitharaman in Parliament recently, talks extensively about mental health, its significance and implications on policy recommendations.
IIT-G discovers RNA-destroying function of p30 protein in African Swine Fever Virus
Indian Institute of Technology Guwahati (IIT-G) researchers have investigated the biochemistry of the African Swine Fever Virus (ASFV) protein, focusing on understanding the biochemical processes of infection to devise effective control strategies.
13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors
The 13th edition of Bengaluru INDIA NANO 2024, organised by the Department of Science & Technology, Government of Karnataka, Karnataka Science & Technology Promotion Society (KSTePS), and Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) concluded on August 3 with participation of 1018 delegates, 11 countries including Korea, Morocco, USA, UK, France, Canada, Germany, Netherlands, Russia, Japan, and Poland, 49 exhibitors comprising 21 startups and 28 industry and institutes, and 200 posters. The exhibition had a footfall of 3,000+ visitors.
Are Nutraceuticals DRUGS? Examining a Needless Regulatory Tussle
The news has been around for a while which has put a big question mark ahead of the Indian nutraceuticals industry.
Can India Reclaim API Throne from China?
Despite having the third-largest pharmaceutical industry by volume in the world and being the largest manufacturer of generic medicines globally, India is heavily dependent on China for imports of raw materials, Key Starting Materials (KSMs), and Active Pharmaceutical Ingredients (APIs).
JRS Pharma & Gujarat Microwax open new manufacturing facility in Mehsana
JRS Pharma, a leading manufacturer of excipients, in partnership with Gujarat Microwax, has commissioned a new manufacturing facility for cotton-based croscarmellose sodium.
NovaLead's patented repurposed drug for treating DFU gets CDSCO approval
Pune-based NovaLead Pharma has announced that the drug regulator in India, Central Drugs Standard Control Organisation (CDSCO), has approved their patented Repurposed Drug for treatment of Diabetic Foot Ulcer (DFU) which is a global unmet medical need.
Medicamen Organics expands footprint in East Africa with $75,000 investment in Rwanda
Delhi-based pharma company Medicamen Organics has taken a significant step in its global expansion strategy by signing a Memorandum of Understanding (MoU) with Depot Pharmacy Yego in Rwanda.
Mankind Pharma acquires 100% stake in Bharat Serums and Vaccines for Rs 13,630 Cr
Mankind Pharma has entered into a definitive agreement to acquire a 100 per cent stake in Bharat Serums and Vaccines Limited (BSV) from Advent International, for an enterprise value of approx.
Thyrocare buys Polo Labs' pathology diagnostic biz to strengthen Northern India presence
Mumbai-based Thyrocare, a leading diagnostic and preventive healthcare service provider in India, has entered into a Business Transfer Agreement with Polo Labs to acquire their pathology diagnostic business.
